₹95.1
▼ -4.9 -4.90%
17 Jul 2026
NSE Listed
Sotac Pharmaceuticals Ltd. (SOTAC)
Volume: 2,400Avg Vol 1W: 720Avg Vol 1M: 13,92052W Range:₹95.1₹139.65
Key Ratios
Checked 17h agoMarket Cap₹105 Cr
Current Price₹95.1
Previous Close₹100
High / Low (52w)₹139.65 / ₹95.1
Volume2,400
Avg Vol (1W)720
Avg Vol (1M)13,920
Stock P/E18.22
Book Value₹53.28
Dividend Yield21%
ROE9.79%
ROA360.1%
Revenue (TTM)₹101 Cr
Revenue Growth-6.6%
Profit Margin424.7%
Total Debt₹14 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹5.22
P/B1.79
Debt / Equity0.7
50 DMA₹106.26
200 DMA₹117.74
Day change-4.90%
Price Chart
₹95.1▼ 23.31% · 1Y
2025-07-182026-07-15
20-day avg volume: 14K shares
Pros
- Pays a dividend yield of 21.0%.
- Company is almost debt-free.
Cons
- Revenue fell 41% YoY.
Quarterly Results
| Metric | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹40 Cr | ₹20 Cr | ₹18 Cr | ₹25 Cr | ₹27 Cr | ₹26 Cr | ₹26 Cr | ₹25 Cr |
| EBITDA | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr |
| Net Profit | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2020 | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | ₹29 Cr | ₹49 Cr | ₹78 Cr | ₹104 Cr | ₹101 Cr |
| EBITDA | ₹1 Cr | ₹-1 Cr | ₹5 Cr | ₹6 Cr | ₹14 Cr |
| Net Profit | ₹0 Cr | ₹-2 Cr | ₹3 Cr | ₹4 Cr | ₹8 Cr |
| EPS | 0.89 | -10.28 | 3.58 | 3.9 | 7.26 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Total Assets | ₹30 Cr | ₹35 Cr | ₹74 Cr | ₹105 Cr | ₹124 Cr |
| Total Liabilities | ₹26 Cr | ₹32 Cr | ₹54 Cr | ₹56 Cr | ₹66 Cr |
| Equity | ₹5 Cr | ₹3 Cr | ₹20 Cr | ₹49 Cr | ₹58 Cr |
| Total Debt | — | — | — | — | — |
Cash Flow
| Metric | Mar 2020 | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹10 Cr | ₹-14 Cr | ₹-4 Cr |
| Investing | ₹-12 Cr | ₹-3 Cr | ₹-12 Cr | ₹-20 Cr | ₹-14 Cr |
| Financing | ₹11 Cr | ₹3 Cr | ₹13 Cr | ₹29 Cr | ₹16 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹10 Cr | ₹-14 Cr | ₹-4 Cr |
Shareholding
Promoter 72.85% Institutions 16.79% Public 10.36%
Efficiency & Working Capital
ROCE13.3%
Interest Coverage5.3
Dividend Payout—
Debtor Days128 d
Inventory Days76 d
Payable Days71 d
Cash Conversion Cycle133 d
Working Capital Days205 d
Shareholding Details
As of 2026-03-31
Promoter72.9%
FII16.8%
DII0%
Institutions16.8%
Public10.4%
Promoter Pledge0%
No. of Shareholders221
Shareholding Pattern
Quarterly — figures in %. Latest 8 quarters.
| Period | Apr 2023 | Apr 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% |
| FIIs | 12.9% | 12.9% | 8.5% | 9% | 8.9% | 15.1% | 16.1% | 16.8% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 14.3% | 14.3% | 18.6% | 18.2% | 18.3% | 12% | 11% | 10.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 784 | 784 | 255 | 245 | 251 | 243 | 240 | 221 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Kiran Baldevbhai Jotania | Shareholding of Promoter and Promoter Group | 13.1% | 14,49,000 |
| Vishalkumar Devrajbhai Patel | Shareholding of Promoter and Promoter Group | 13% | 14,31,500 |
| Dineshkumar Babulal Gelot | Shareholding of Promoter and Promoter Group | 13% | 14,31,500 |
| Sharadkumar Dashrathbhai Patel | Shareholding of Promoter and Promoter Group | 13% | 14,31,500 |
| Chetankumar Bachubhai Patel | Shareholding of Promoter and Promoter Group | 9.7% | 10,69,250 |
| Nav Capital Vcc - Nav Capital Emerging Star Fund | Public Shareholding | 7.4% | 8,12,400 |
| Shaileshkumar Vishnuprasad Patel | Shareholding of Promoter and Promoter Group | 7.3% | 8,05,000 |
| Craft Emerging Market Fund Pcc- Elite Capital Fund | Public Shareholding | 7.1% | 7,87,200 |
| Mitul Shaileshkumar Patel | Shareholding of Promoter and Promoter Group | 3.3% | 3,62,250 |
| Minerva Ventures Fund | Public Shareholding | 1.6% | 1,81,200 |
| Kashyapkumar Rajendrakumar Mehta | Public Shareholding | 1.5% | 1,70,400 |
| Walpar Nutritions Limited | Public Shareholding | 1.5% | 1,64,400 |
| Pinki Sharadkumar Patel | Shareholding of Promoter and Promoter Group | 0.2% | 17,500 |
| Dhara Chetankumar Patel | Shareholding of Promoter and Promoter Group | 0.2% | 17,500 |
| Vasantkumar Devrajbhai Patel | Shareholding of Promoter and Promoter Group | 0.2% | 17,500 |
| Sarojben Dineshkumar Gelot | Shareholding of Promoter and Promoter Group | 0.2% | 17,500 |
| Dashrathbhai Ramabhai Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Narmadaben Dashrathbhainpatel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sanjay Dashrathbhai Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dipikaben Nileshkumar Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rekhaben Saileshkumar Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bhavanaben Manishkumarnpatel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aarav Sharadkumar Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Krishna Sharadkumar Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Manubhai Sakalchand Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Chetankumar Bachubhai Patel | 0 | 0% | 2026-03-31 |
| Dineshkumar Babulal Gelot | 0 | 0% | 2026-03-31 |
| Sharadkumar Dashrathbhai Patel | 0 | 0% | 2026-03-31 |
| Kiran Baldevbhai Jotania | 0 | 0% | 2026-03-31 |
| Vishalkumar Devrajbhai Patel | 0 | 0% | 2026-03-31 |
| Dhara Chetankumar Patel | 0 | 0% | 2026-03-31 |
| Vasantkumar Devrajbhai Patel | 0 | 0% | 2026-03-31 |
| Sarojben Dineshkumar Gelot | 0 | 0% | 2026-03-31 |
| Shaileshkumar Vishnuprasad Patel | 0 | 0% | 2026-03-31 |
| Pinki Sharadkumar Patel | 0 | 0% | 2026-03-31 |
| Mitul Shaileshkumar Patel | 0 | 0% | 2026-03-31 |
| Dashrathbhai Ramabhai Patel | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sharadkumar Dashrathbhai Patel | Chairman & Managing Director | 2025 |
| Dineshkumar Babulal Gelot | Whole-time Director | 2025 |
| Vishalkumar Devrajbhai Patel | Executive Director | 2025 |
| Chetankumar Bachubhai Patel | Executive Director | 2025 |
| Bhavinkumar Prafulbhai Joshi | Independent Non Exe. Director | 2025 |
| Ketankumar Arvindbhai Modi | Independent Non Exe. Director | 2025 |
| Dimpal Dhebarbhai Pate | Independent Non Exe. Director | 2025 |
| Niyati Dipesh Parikh | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 12 | 11 | 11 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-19 | ₹0.1 (1%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 1 | 45 | 46 |
| 2025 | 0 | 0 | 0 | 0 | 26 | 26 |
| 2025 | 0 | 0 | 0 | 1 | 1 | 2 |
Company Information
Incorporated2015
ChairmanSharadkumar Dashrathbhai Patel
AuditorKeyur Shah & Co
Investor Email[email protected]
📍 Plot No PF-21 Nr ACME Pharma, Opp Teva Pharma Sanand GIDC-II, Ahmedabad, Gujarat, 382110
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search